| http://www.w3.org/ns/prov#value | - Primary cross referrals between disciplines occurred in 40 (33.3%) cases, including 12 of 46 (26%) prostate cancer, compared to 66.7% testicular cancers and 42% bladder cancers (p < 0.02).ConclusionsThe MDM alters the treating clinician's management in about a quarter of prostate cancer cases, more so with evident metastatic disease.
|